Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome.Dario Ferrero, Mario Boccadoro, Silvia Campana et al.|PubMed|2004Cited by 29
Prognostic Evaluation of Myelodysplastic Syndromes (MDS): Analysis of Deaths Due to Age-Related Causes.Flavia Salvi, Alessandro Levis, Daniela Gioia et al.|Blood|2005Cited by 4
A Maintenance Therapy with Differentiating Agents and Low-Dose Chemotherapy Increases Remission Duration and Survival in High Risk AML and MDS Patients.Dario Ferrero, Mario Boccadoro, Chiara Maria Dellacasa et al.|Blood|2005Cited by 0